Sort by
Between Displacement and Uncertainty: Depressive Symptoms and Quality of Life in Refugees in Serbia
Milena Stevanovic
,Marko Latas
,Milan Latas
,Marija Milic
,Natasa Milic
,Darija Kisic
,Zorana Pavlovic
Posted: 14 April 2026
Real World Evidence on Perceived Effectiveness, Quality of Life Impact, and Public Attitudes Toward a Common Cold and Flu Medication: A Cross-Sectional Study
Bibi Fatima Choonara
,Morten Georg Jensen
,Nishern Govender
,Ahmed Hamdy
,Aida Gadzhieva
,Rachel Lee-Yin Tan
,Bangalee Varsha
Posted: 14 April 2026
The Otoacoustic Emissions in the Universal Neonatal Hearing Screening in China and India: An Update on the Asian States (2005 to 2025)
Stavros Hatzopoulos
,Ludovica Cardinali
,Piotr Henryk Skarzynski
,Giovanna Zimatore
Posted: 14 April 2026
Maternal Dietary Quality During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-Analysis
Temitope Toyon
,Caroline Afolabi
,Doris I. Anaemene
,Joseph Adekunle
Posted: 14 April 2026
Delayed Neuropathy Following Long-Term Organophosphate Exposure in a Pesticide Applicator: A Case Report
Gudisa Bereda
Posted: 14 April 2026
Association of a Smartphone-Based mHealth Intervention with Knowledge, Attitude, and Practice Regarding Treatment Adherence and Adverse Events Among Patients with Multidrug-Resistant Tuberculosis in Vietnam: A Nested Cross-Sectional Study Within the V-SMART Randomised Controlled Trial
Huy Le Ngoc
,Hoa Nguyen Binh
,Giang Le Minh
,Luong Dinh Van
Posted: 14 April 2026
Development and Prototype Implementation of a Dehydration Risk Prediction Model Based on Meta-Analytic Evidence
Melvin Omone Ogbolu
,Olanrewaju D. Eniade
,Alex Ugochukwu Gbenimachor
,Miklós Kozlovszky
Posted: 14 April 2026
Evaluating Public Health Education for the Prevention of Mother-to-Child HIV Transmission Among Pregnant Women in Cross River State, Nigeria
Ojong Ofut Ogar
,Lawrence Ayah Iruo
,Morufu Olalekan Raimi
Posted: 14 April 2026
Evolving Health Policies and Pricing Dynamics in U.S. Multiple Sclerosis Therapies: A Longitudinal Analysis with Policy Implications
Serdar Kuzu
,Ali Kablan
,Murat Kirişci
,Zehra Koyuncu
Background and Objectives: Multiple sclerosis (MS) is a chronic autoimmune neuroinflammatory condition associated with significant disability. Given the increasing number of patients with MS, the growing number of available disease-modifying therapies (DMTs), and the substantial economic burden associated with MS, it is critically important to determine which treatment options are the most cost-effective. The economic burden of MS is considerable, and high-cost DMTs, whose prices continue to rise, represent the primary driver of health expenditures related to MS. The primary aim of this narrative review is to provide a brief review of the economic issues related to MS DMTs, including pricing trends, economic burden, and their impact on patient care, and to propose potential policy solutions. Materials and Methods: The aim of the study was to compare the cost effectiveness of The annual costs of DMTs from 1993 to 2023 in USA. An examination of DMT pricing trends suggests that pricing has been influenced in part by within-class competition and the availability of generic DMT options. Results: Over the past decade, the prices of DMTs have increased by more than 50%. Currently, the annual cost of many DMTs used in the treatment of MS has exceeded $100,000, and their economic value is widely debated. The high cost of DMTs and difficulties in timely access to medications can lead to psychological stress among many patients. Studies on cost-effectiveness indicate that the clinical benefits provided by DMTs do not fully justify their high costs, which further exacerbates issues related to economic accessibility. Conclusions: Collaborative neuropsychiatric care models, in which neurologists and mental health professionals work in coordination, may improve symptom recognition, optimize adherence to DMTs, and enhance overall functioning. Given that treatment non-adherence and reduced quality of life negatively affect cost-effectiveness outcomes, early psychiatric intervention may indirectly improve the economic value profile of high-cost DMTs.
Background and Objectives: Multiple sclerosis (MS) is a chronic autoimmune neuroinflammatory condition associated with significant disability. Given the increasing number of patients with MS, the growing number of available disease-modifying therapies (DMTs), and the substantial economic burden associated with MS, it is critically important to determine which treatment options are the most cost-effective. The economic burden of MS is considerable, and high-cost DMTs, whose prices continue to rise, represent the primary driver of health expenditures related to MS. The primary aim of this narrative review is to provide a brief review of the economic issues related to MS DMTs, including pricing trends, economic burden, and their impact on patient care, and to propose potential policy solutions. Materials and Methods: The aim of the study was to compare the cost effectiveness of The annual costs of DMTs from 1993 to 2023 in USA. An examination of DMT pricing trends suggests that pricing has been influenced in part by within-class competition and the availability of generic DMT options. Results: Over the past decade, the prices of DMTs have increased by more than 50%. Currently, the annual cost of many DMTs used in the treatment of MS has exceeded $100,000, and their economic value is widely debated. The high cost of DMTs and difficulties in timely access to medications can lead to psychological stress among many patients. Studies on cost-effectiveness indicate that the clinical benefits provided by DMTs do not fully justify their high costs, which further exacerbates issues related to economic accessibility. Conclusions: Collaborative neuropsychiatric care models, in which neurologists and mental health professionals work in coordination, may improve symptom recognition, optimize adherence to DMTs, and enhance overall functioning. Given that treatment non-adherence and reduced quality of life negatively affect cost-effectiveness outcomes, early psychiatric intervention may indirectly improve the economic value profile of high-cost DMTs.
Posted: 13 April 2026
Epidemiological Transition and the Crisis of the Treatment Model: The Need for a Shift Toward Preventive and Integrative Healthcare
Alexander Dmitriev
Posted: 13 April 2026
Sarcopenia in Tenerife: Prevalence, Multidimensional Vulnerability, and the Socio-Economic Case for Prevention and Treatment
Vicente Llinares Arvelo
,Carlos Enrique Martinez Alberto
,Serafín Corral
Posted: 13 April 2026
Forecasting Assisted Living Demand in Singapore: Evidence-Based ARIMA Projections to Inform Policy and Practice
Ang Amberyce
Posted: 13 April 2026
An Integrated Care Pathway for Pediatric Oral Health: A Multicenter Study on Dental Caries, Malocclusions, and Oral Hygiene in Three Italian Regions
Erika Roncarati
,Dorina Lauritano
,Saverio Ceraulo
,Luigi Baggi
,Roberta Calcaterra
,Roberto Gatto
,Sivia Caruso
,Stefano Cianetti
,Guido Lombardo
,Francesco Carinci
Posted: 13 April 2026
Diagnostic Performance Evaluation of the GXT96 X3 Extraction System with the FluoroType® SARS-CoV-2 varID Q Assay for Detection and Variant Identification of SARS-CoV-2
Riffat Munir
,Oluwakemi Laguda-Akingba
,Lesley Erica Scott
,Wendy Susan Stevens
Posted: 10 April 2026
Biomechanical Evaluation of a Biomimetic Stand-Assist Toilet Seat in Older Adults: A Synchronized AI-Kinematic and Kinetic Analysis
Shan-Ju Yeh
,Shu-Yu Yang
,Li-Chi Chao
,Tsai-Sui Lu
,Yu-Sheng Yang
Posted: 10 April 2026
Depressive Symptoms and Their Associations with Tuberculosis-Related Knowledge, Attitudes, and Practices Among Patients with Multidrug-Resistant Tuberculosis
Huy Le Ngoc
Posted: 10 April 2026
Podiatrists Decrease the Odds of Major Amputation in Patients with Diabetes and/or Peripheral Arterial Disease in All Practice Settings: A Retrospective Administrative Claims Data Analysis
Chia-Ding Shih
,Tina Javanbakht
,Dyane E. Tower
,Rachel H. Albright
,Tze-Woei Tan
,Brandon Brooks
,James S. Wrobel
Posted: 10 April 2026
Exposing the Value of Receiving and Giving Help Across 12 European Countries: A Longitudinal Analysis of Self-Perceived Health
Hans Gevers
Posted: 10 April 2026
Association of Positive mHealth Engagement with Knowledge, Attitude, Practice, and Total KAP Among Patients with Multidrug-Resistant Tuberculosis
Huy Ngoc Le
,Giang Minh Le
,Hoa Binh Nguyen
,Luong Van Dinh
Posted: 09 April 2026
“The Most High-Risk People are Given the Most High- Risk Drugs in the Most High-Risk Way”: Experiences of Treating Problematic Over the Counter and Prescription Only Medication Use in Substance Misuse Services
Rosalind Gittins
,Roya Vaziri
,Ian Maidment
Posted: 09 April 2026
of 308